Market Overview

Benzinga's Top Initiations

Related PFE
MedGenesis Announces Deal with Pfizer Related to Possible Treatments for Parkinson's
Benzinga's Weekend M&A Chatter
Martoma Hit with Nine-Year Prison Sentence (Fox Business)
Related GRMN
Morgan Stanley Sees Stiffer-Than-Expected Fall Competition From Nike For Garmin Ltd.
Markets Little Changed In Low Volume And Slow News Ahead Of Long Weekend
Fitness Bands, Dog Collars Propel Garmin to 1Q Beat (Fox Business)

Analysts at Deutsche Bank initiated coverage on Pfizer (NYSE: PFE) with a Buy rating. The target price for Pfizer is set to $34. Pfizer's shares closed at $29.21 yesterday.

Baird initiated coverage on shares of Garmin (NASDAQ: GRMN) with a Neutral rating. The target price for Garmin is set to $59. Garmin's shares closed at $57.46 yesterday.

Analysts at DA Davidson initiated coverage on shares of Oracle (NASDAQ: ORCL) with a Neutral rating. The target price for Oracle is set to $46. Oracle's shares closed at $41.84 yesterday.

Analysts at Jefferies initiated coverage on MannKind (NASDAQ: MNKD) with a Buy rating. The target price for MannKind is set to $10. MannKind's shares closed at $7.34 yesterday.

Latest Ratings for PFE

DateFirmActionFromTo
Aug 2014Deutsche BankInitiates Coverage onBuy
Jul 2014BMO CapitalDowngradesOutperformMarket Perform
Jul 2014JefferiesMaintainsBuy

View More Analyst Ratings for PFE
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (GRMN + MNKD)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters